NCT05980416 2025-11-14
Study of EO-3021 in Adult Patients With Solid Tumors Likely to Express CLDN18.2
Elevation Oncology
Phase 1 Terminated
Clinical Trials
6 trialsNCT04137289 2025-03-25
A Study to Find a Safe and Effective Dose of BI 905711 in Patients With Advanced Gastrointestinal Cancer
Boehringer Ingelheim
Phase 1 Completed
NCT05087992 2025-02-19
A Study to Find the Best Dose of BI 905711 in Combination With Chemotherapy and to Test Whether This Dose Helps People With Advanced Gastrointestinal Cancers
Boehringer Ingelheim
Phase 1 Completed
NCT03343301 2024-02-28
FIGHT
Five Prime Therapeutics, Inc.
Phase 1 Completed
NCT03449030 2021-03-22
A Study of TAK-164 in Participants With Advanced Gastrointestinal (GI) Cancer Expressing Guanylyl Cyclase C (GCC)
Takeda
Phase 1 Terminated
NCT00585637 2015-04-01
Vitamin D for Chemoprevention
Dana-Farber Cancer Institute
Phase 1 Completed